Literature DB >> 1762914

Constitutive expression of the urokinase plasminogen activator gene in murine RAW264 macrophages involves distal and 5' non-coding sequences that are conserved between mouse and pig.

A I Cassady1, K J Stacey, K A Nimmo, K M Murphy, D von der Ahe, D Pearson, F M Botteri, Y Nagamine, D A Hume.   

Abstract

The 5' flanking regions of the mouse and pig urokinase plasminogen activator (uPA) genes were sequenced and sequence homology interrupted by repeat elements was found to extend to -4.6kb in pig and -6.6kb in mouse. A transient transfection procedure was devised for the murine macrophage cell line RAW264. Pig uPA promoter-CAT constructs were more active than mouse constructs in this assay. This contrast may involve sequence differences within 100 bp of the transcription start site. The selective deletion of distal regions of the promoter (greater than 2.6 kb upstream), and of a conserved element, 5'-AGGAGGAAATGAGG-TCA-3' around -2 kb greatly reduced the activity of reporter constructs in RAW264 cells. Electrophoretic mobility shift assays using the latter sequence identified a single nuclear protein complex. This element has been referred to as PEA3/AP1-like, but the complex did not comigrate with either AP1 or known proteins that bind polypurines (including the macrophage-specific factor PU-1) and was not competed by AP1 or polypurine oligonucleotides. uPA promoters contain multiple AP1 and AP2-like DNA sequences, which were recognised by nuclear proteins expressed constitutively in RAW264 cells. They also contain multiple binding sites for NF kappa B but activated NF kappa B was not expressed in RAW264 cells. The conserved, transcribed 5' non-coding sequences were also required for maximal gene expression. Hence, the uPA promoter contains multiple weak cis-acting elements distributed over 7.0 kb 5' to the translation start site.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1762914      PMCID: PMC329318          DOI: 10.1093/nar/19.24.6839

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  43 in total

1.  A new method for sequencing DNA.

Authors:  A M Maxam; W Gilbert
Journal:  Proc Natl Acad Sci U S A       Date:  1977-02       Impact factor: 11.205

Review 2.  Plasminogen activators, tissue degradation, and cancer.

Authors:  K Danø; P A Andreasen; J Grøndahl-Hansen; P Kristensen; L S Nielsen; L Skriver
Journal:  Adv Cancer Res       Date:  1985       Impact factor: 6.242

3.  The human urokinase-plasminogen activator gene and its promoter.

Authors:  A Riccio; G Grimaldi; P Verde; G Sebastio; S Boast; F Blasi
Journal:  Nucleic Acids Res       Date:  1985-04-25       Impact factor: 16.971

4.  DNA binding and I kappa B inhibition of the cloned p65 subunit of NF-kappa B, a rel-related polypeptide.

Authors:  G P Nolan; S Ghosh; H C Liou; P Tempst; D Baltimore
Journal:  Cell       Date:  1991-03-08       Impact factor: 41.582

5.  Regulation of interaction of the iron-responsive element binding protein with iron-responsive RNA elements.

Authors:  D J Haile; M W Hentze; T A Rouault; J B Harford; R D Klausner
Journal:  Mol Cell Biol       Date:  1989-11       Impact factor: 4.272

6.  Multiple nuclear factors interact with promoter sequences of the urokinase-type plasminogen activator gene.

Authors:  D von der Ahe; D Pearson; J Nakagawa; B Rajput; Y Nagamine
Journal:  Nucleic Acids Res       Date:  1988-08-11       Impact factor: 16.971

7.  The murine urokinase-type plasminogen activator gene.

Authors:  S J Degen; J L Heckel; E Reich; J L Degen
Journal:  Biochemistry       Date:  1987-12-15       Impact factor: 3.162

8.  Modulation of urokinase plasminogen activator gene expression during the transition from quiescent to proliferative state in normal mouse cells.

Authors:  G Grimaldi; P Di Fiore; E K Locatelli; J Falco; F Blasi
Journal:  EMBO J       Date:  1986-05       Impact factor: 11.598

9.  Gamma interferon enhances macrophage transcription of the tumor necrosis factor/cachectin, interleukin 1, and urokinase genes, which are controlled by short-lived repressors.

Authors:  M A Collart; D Belin; J D Vassalli; S de Kossodo; P Vassalli
Journal:  J Exp Med       Date:  1986-12-01       Impact factor: 14.307

10.  Glucocorticoid-modulated gene expression of tissue- and urinary-type plasminogen activator and plasminogen activator inhibitor 1 and 2.

Authors:  R L Medcalf; E Van den Berg; W D Schleuning
Journal:  J Cell Biol       Date:  1988-03       Impact factor: 10.539

View more
  21 in total

1.  Regulation of proteinases during mouse peri-implantation development: urokinase-type plasminogen activator expression and cross talk with matrix metalloproteinase 9.

Authors:  M G Martínez-Hernández; L A Baiza-Gutman; A Castillo-Trápala; D Randall Armant
Journal:  Reproduction       Date:  2010-11-12       Impact factor: 3.906

2.  Alterations in differentiation and behavior of monocytic phagocytes in transgenic mice that express dominant suppressors of ras signaling.

Authors:  D I Jin; S B Jameson; M A Reddy; D Schenkman; M C Ostrowski
Journal:  Mol Cell Biol       Date:  1995-02       Impact factor: 4.272

3.  Synergistic transcriptional activation of the mouse urokinase plasminogen activator (uPA) gene and of its enhancer activator protein 1 (AP1) site by cAMP and retinoic acid.

Authors:  R Mira-Y-Lopez; S Jaramillo; Y Jing
Journal:  Biochem J       Date:  1998-05-01       Impact factor: 3.857

4.  Pocket protein-independent repression of urokinase-type plasminogen activator and plasminogen activator inhibitor 1 gene expression by E2F1.

Authors:  M Koziczak; W Krek; Y Nagamine
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

5.  Persistent activation of mitogen-activated protein kinases p42 and p44 and ets-2 phosphorylation in response to colony-stimulating factor 1/c-fms signaling.

Authors:  L F Fowles; M L Martin; L Nelsen; K J Stacey; D Redd; Y M Clark; Y Nagamine; M McMahon; D A Hume; M C Ostrowski
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

6.  Expression of mRNA encoding the macrophage colony-stimulating factor receptor (c-fms) is controlled by a constitutive promoter and tissue-specific transcription elongation.

Authors:  X Yue; P Favot; T L Dunn; A I Cassady; D A Hume
Journal:  Mol Cell Biol       Date:  1993-06       Impact factor: 4.272

7.  Macrophage nitric oxide synthase gene: two upstream regions mediate induction by interferon gamma and lipopolysaccharide.

Authors:  C J Lowenstein; E W Alley; P Raval; A M Snowman; S H Snyder; S W Russell; W J Murphy
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-15       Impact factor: 11.205

8.  Effects of the tat and nef gene products of human immunodeficiency virus type 1 (HIV-1) on transcription controlled by the HIV-1 long terminal repeat and on cell growth in macrophages.

Authors:  K M Murphy; M J Sweet; I L Ross; D A Hume
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

9.  Genomic organization and sequence of the human NRAMP gene: identification and mapping of a promoter region polymorphism.

Authors:  J M Blackwell; C H Barton; J K White; S Searle; A M Baker; H Williams; M A Shaw
Journal:  Mol Med       Date:  1995-01       Impact factor: 6.354

10.  Cytoskeletal reorganization and TPA differently modify AP-1 to induce the urokinase-type plasminogen activator gene in LLC-PK1 cells.

Authors:  J S Lee; D von der Ahe; B Kiefer; Y Nagamine
Journal:  Nucleic Acids Res       Date:  1993-07-25       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.